Centene Corp. Stock
Centene Corp. Stock
With 28 Buy predictions and not a single Sell prediction Centene Corp. is an absolute favorite of our community.
With a target price of 82 € there is a slightly positive potential of 19.31% for Centene Corp. compared to the current price of 68.73 €.
So far the community has only identified positive things for Centene Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Centene Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Centene Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Centene Corp. | -0.100% | 3.136% | -2.992% | 8.151% | 2.889% | 23.838% | 64.899% |
| UnitedHealth Group Inc. | 0.440% | -2.244% | -0.267% | 14.879% | 9.696% | 46.026% | 150.036% |
| Humana Inc. | 0.320% | -4.634% | -10.664% | -35.978% | -31.318% | -18.297% | 12.855% |
| Cigna Corp. | -0.200% | -1.248% | 3.187% | 20.037% | 18.353% | 82.777% | 119.792% |
Comments
Centene Co. (NYSE: CNC) had its price target lowered by analysts at Wells Fargo & Company from $93.00 to $91.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNC provided by MarketBeat
Centene Co. (NYSE: CNC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $90.00 price target on the stock.
Show more
Ratings data for CNC provided by MarketBeat
Centene Co. (NYSE: CNC) had its price target lowered by analysts at Barclays PLC from $98.00 to $97.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNC provided by MarketBeat
News
Centene (CNC) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Centene (NYSE: CNC)Q2 2024 Earnings CallJul 26, 2024, 8:30 a.m. ET
Operator
Source Fool.com
Centene Reaffirms Guidance, But Is it Too Late?
Managed care health insurance company Centene Inc. (NYSE: CNC) recently saw its share rebound after reaffirming its guidance. This move came just after UnitedHealth Group Inc. (NYSE: UNH) made
Centene (CNC) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Centene (NYSE: CNC)Q1 2024 Earnings CallApr 26, 2024, 8:30 a.m. ET
Operator
Source Fool.com